Effect of urocortin 1 infusion in humans with stable congestive cardiac failure

Clinical Science

Volumn 109, Issue 4, 2005, Pages 381-388

  Davis, Mark E ^a   Pemberton, Christopher J ^a   Yandle, Timothy G ^a   Lainchbury, John G ^a   Rademaker, Miriam T ^a   Nicholls, M Gary ^b   Frampton, Christopher M ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Corticotropin ('ACTH'); Cortisol; Ghrelin; Heart failure; Urocortin 1

Indexed keywords

CORTICOTROPIN; GHRELIN; HYDROCORTISONE; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN I;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG HALF LIFE; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADRENOCORTICOTROPIC HORMONE; AGED; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; CROSS-OVER STUDIES; HALF-LIFE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM;

EID: 26844502375     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050079     Document Type: Article

References (55)

1. Vaughan, J., Donaldson, C., Bittencourt, J. et al. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Nature (London) 378, 287-292
2. Iino, K., Sasano, H., Oki, Y. et al. (1999) Urocortin expression in the human central nervous system. Clin. Endocrinol. 50, 107-114
3. Takahashi, K., Totsune, K., Sone, M. et al. (1998) Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19, 643-647
4. Nishikimi, T., Miyata, A., Horio, T. et al. (2000) Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am. J. Physiol. Heart Circ. Physiol. 279, H3031-H3039
5. Kimura, Y., Takahashi, K., Totsune, K. et al. (2002) Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J. Clin. Endocrinol. Metab. 87, 340-346
6. Okosi, A., Brar, B. K., Chan, M. et al. (1998) Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 32, 167-171
7. Kozicz, T. and Arimura, A. (2002) Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23, 515-521
8. Muramatsu, Y., Fukushima, K., Iino, K. et al. (2000) Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21, 1799-1809
9. Chen, A., Blount, A., Vaughan, J., Brar, B. and Vale, W. (2004) Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in CRF1 and CRF2-null mice and regulation by glucocorticoids. Endocrinology 145, 2445-2457
10. Seres, J., Bornstein, S. R., Seres, P. et al. (2004) Corticotropin- releasing hormone system in human adipose tissue. J. Clin. Endocrinol. Metab. 89, 965-970
11. Bamberger, C. M., Wald, M., Bamberger, A. M., Ergun, S., Beil, F. U. and Schulte, H. M. (1998) Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83, 708-711
12. Kempuraj, D., Papadopoulou, N. G., Lytinas, M. et al. (2004) Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145, 43-48
13. Baigent, S. M. and Lowry, P. J. (2000) mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J. Mol. Endocrinol. 25, 43-52
14. Petraglia, F., Florio, P., Gallo, R. et al. (1996) Human placenta and fetal membranes express human urocortin mRNA and peptide. J. Clin. Endocrinol. Metab. 81, 3807-3810
15. Slominski, A., Roloff, B., Curry, J., Dahiya, M., Szczesniewski, A. and Wortsman, J. (2000) The skin produces urocortin. J. Clin. Endocrinol. Metab. 85, 815-823
16. Kohno, M., Kawahito, Y., Tsubouchi, Y. et al. (2001) Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J. Clin. Endocrinol. Metab. 86, 4344-4352
17. Pedersen, W. A., Wan, R., Zhang, P. and Mattson, M. P. (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22, 404-412
18. Martinez, V., Wang, L., Rivier, J. E., Vale, W. and Tache, Y. (2002) Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther. 301, 611-617
19. Guzman, E. A., Zhang, W., Lin, T. R. and Mulholland, M. W. (2003) Stimulation of rat pancreatic exocrine secretion by urocortin and corticotropin releasing factor. Peptides 24, 727-734
20. Spina, M., Merlo-Pich, E., Chan, R. K. et al. (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273, 1561-1564
21. Brar, B. K., Jonassen, A. K., Stephanou, A. et al. (2000) Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 275, 8508-8514
22. + channels. Br. J. Pharmacol. 135, 1467-1476
23. Latchman, D. S. (2001) Urocortin protects against ischemic injury via a MAPK-dependent pathway. Trends Cardiovasc. Med. 11, 167-169
24. Ikeda, K., Tojo, K., Sato, S. et al. (1998) Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem. Biophys. Res. Commun. 250, 298-304
25. Ikeda, K., Tojo, K., Tokudome, G. et al. (2003) Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases. Mol. Cell. Biochem. 252, 25-32
26. Rademaker, M. T., Charles, C. J., Espiner, E. A. et al. (2002) Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J. Am. Coll. Cardiol. 40, 1495-1505
27. Reyes, T. M., Lewis, K., Perrin, M. H. et al. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 2843-2848
28. Hsu, S. Y. and Hsueh, A. J. (2001 Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7, 605-611
29. Lewis, K., Li, C., Perrin, M. H. et al. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 7570-7575
30. Chanalaris, A., Lawrence, K. M., Stephanou, A. et al. (2003) Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. J. Mol. Cell. Cardiol. 35, 1295-1305
31. Davis, M. E., Pemberton, C. J., Yandle, T. G. et al. (2004) Urocortin-1 infusion in normal humans. J. Clin. Endocrinol. Metab. 89, 1402-1409
32. Steiner, A. L., Wehmann, R. E., Parker, C. W. and Kipnis, D. M. (1972) Radioimmunoassay for the measurement of cyclic nucleotides. Adv. Cyclic Nucleotide Res. 2, 51-61
33. Pemberton, C., Wimalasena, P., Yandle, T., Soule, S. and Richards, M. (2003) C-terminal pro-ghrelin peptides are present in the human circulation. Biochem. Biophys. Res. Commun. 310, 567-573
34. Lewis, J. G., Manley, L., Whitlow, J. C. and Elder, P. A. (1992) Production of a monoclonal antibody to cortisol: application to a direct enzyme-linked immunosorbent assay of plasma. Steroids 57, 82-85
35. Inder, W. J., Hellemans, J., Ellis, M. J., Evans, M. J., Livesey, J. H. and Donald, R. A. (1995) Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes. J. Clin. Endocrinol. Metab. 80, 244-248
36. Yandle, T. G., Richards, A. M., Gilbert, A., Fisher, S., Holmes, S. and Espiner, E. A. (1993) Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J. Clin. Endocrinol. Metab. 76, 832-838
37. Yandle, T. G., Espiner, E. A., Nicholls, M. G. and Duff, H. (1986) Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J. Clin. Endocrinol. Metab. 63, 72-79
38. Hunt, P. J., Richards, A. M., Nicholls, M. G., Yandle, T. G., Doughty, R. N. and Espiner, E. A. (1997) Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin. Endocrinol. 47, 287-296
39. Nussberger, J., de Gasparo, M., Juillerat, L. et al. (1987) Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A. Clin. Exp. Hypertens. A9, 1353-1366
40. Lun, S., Espiner, E. A., Nicholls, M. G. and Yandle, T. G. (1983) A direct radioimmunoassay for aldosterone in plasma. Clin. Chem. 29, 268-271
41. Goldstein, D. S., Feuerstein, G., Izzo, Jr, J. L., Kopin, I. J. and Keiser, H. R. (1981) Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci. 28, 467-475
42. Kitamura, K., Tanaka, T., Kato, J., Eto, T. and Tanaka, K. (1989) Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem. Biophys. Res. Commun. 161, 348-352
43. Lewis, L. K., Smith, M. W., Yandle, T. G., Richards, A. M. and Nicholls, M. G. (1998) Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin. Chem. 44, 571-577
44. Ng, L. L., Loke, I. W., O'Brien, R. J., Squire, I. B. and Davies, J. E. (2004) Plasma urocortin in human systolic heart failure. Clin. Sci. 106, 383-388
45. Asaba, K., Makino, S. and Hashimoto, K. (1998) Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone. Brain Res. 806, 95-103
46. Asaba, K., Makino, S., Nishiyama, M. and Hashimoto, K. (2000) Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin. J. Cardiovasc. Pharmacol. 36, 493-497
47. Li, C., Chen, P., Vaughan, J. et al. (2003) Urocortin III is expressed in pancreatic β-cells and stimulates insulin and glucagon secretion. Endocrinology 144, 3216-3224
48. Saad, M. F., Bernaba, B., Hwu, C. M. et al. (2002) Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab. 87, 3997-4000
49. Rigamonti, A. E., Pincelli, A. I., Corra, B. et al. (2002) Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J. Endocrinol. 175, R1-R5
50. Bale, T. L., Hoshijima, M., Gu, Y. et al. (2004) The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc. Natl. Acad. Sci. U.S.A. 101, 3697-3702
51. Seasholtz, A. F., Valverde, R. A. and Denver, R. J. (2002) Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J. Endocrinol. 175, 89-97
52. Behan, D. P., De Souza, E. B., Lowry, P. J., Potter, E., Sawchenko, P. and Vale, W. W. (1995) Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front. Neuroendocrinol. 16, 362-382
53. Woods, R. J., Grossman, A., Saphier, P. et al. (1994) Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J. Clin. Endocrinol. Metab. 78, 73-76
54. Wiley, K. E. and Davenport, A. P. (2004) CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br. J. Pharmacol. 143, 508-514
55. Gardiner, S. M., March, J. E., Kemp, P. A., Davenport, A. P., Wiley, K. E. and Bennett, T. (2005) Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats. J. Pharmacol. Exp. Ther. 312, 53-60